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Hematogenous carcinoma metastasis is associated with
tumor cell emboli formation, which is now known to be
facilitated by selectins. P-selectin-mediated interactions of
platelets with cancer cells are based mostly on mucin- and
glycosaminoglycan-type selectin ligands. We previously
showed that mouse colon carcinoma cells (MC-38) carry
P-selectin ligands of nonmucin origin, which were not
identiﬁed. Here we show that P-selectin ligands recognized
on MC-38 cells are sulfated glycolipids, thereby facilitat-
ing experimental metastasis in a syngeneic mouse model.
Metabolic inhibition of sulfation by incubation of cells
with sodium chlorate almost completely abrogated P-
selectin binding. Metabolic labeling of MC-38 cells with
35S sulfate revealed only a single band as detected by
high-performance thin layer chromatography analysis of a
total lipid extract. Matrix-assisted laser desorption/
ionization tandem time-of-ﬂight/time-of-ﬂight analysis
(MALDI-TOF-TOF) analysis of the puriﬁed sulfate-
containing lipid fraction identiﬁed the selectin ligand
to be a sulfated galactosylceramide SM4 (HSO3-
3Galb-1Cer). Modulation of glycolipid biosynthesis in
MC-38 cells altered P-selectin binding, thereby conﬁrming
sulfoglycolipids to be major P-selectin ligands. In
addition, P-selectin was also found to recognize
lactosylceramide sulfate SM3 (HSO3-3Galb-4Glcb-1Cer)
and gangliotriaosylceramide sulfate SM2 [GalNAcb-
4(HSO3-3)Galb-4Glcb-1Cer] in human hepatoma cells.
Finally, the enzymatic removal of sulfation from the cell
surface of MC-38 cells resulted in decreased P-selectin
binding and led to attenuation of metastasis. Thus, SM4
sulfatide serves as a native ligand for P-selectin contribut-
ing to cell–cell interactions and to facilitation of
metastasis.
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Introduction
A common phenotypic change associated with malignancy
is the dramatic alteration of cellular glycosylation.
Differences in the expression of glycoproteins and glyco-
sphingolipids were predominantly deﬁned by monoclonal
antibodies (Hakomori 1996; Kim and Varki 1997; Kannagi
et al. 2004). Structural identiﬁcation of glycolipid antigens
revealed that not all glycans are uniquely “tumor-speciﬁc”,
yet are predominantly present on tumors. Signiﬁcant corre-
lations between aberrant glycosylation of primary tumors and
clinical prognosis have stimulated interest into identiﬁcation
of their biological function (Irimura et al. 1993; Kim and
Varki 1997; Kannagi et al. 2004). Tumor cell carbohydrates
were shown to participate in cell–cell interactions, and glyco-
sphingolipids in particular were identiﬁed as potential effec-
tors of signal transduction (Hakomori 1985; Kannagi et al.
2004).
Sulfatides are a class of sulfate-containing glycosylcera-
mides distributed in various tissues, including the brain,
kidney, and gastrointestinal tract (Natomi et al. 1993;
Ishizuka 1997). Biosynthesis of sulfatides requires transfer of
sulfate to the glycolipid moiety, which is catalyzed by a
unique cerebroside sulfotransferase (CST) (Honke et al.
1997; Hirahara et al. 2000). The physiological function of
sulfated glycosylceramides has been investigated in mice
lacking the CST gene, which caused a complete absence of
sulfatides (Honke et al. 2002; Ishibashi et al. 2002). The lack
of sulfatides resulted in neurological disorders and arrest of
spermatogenesis. Several studies provided evidence that sul-
fatides expressed on cell surfaces of different cells exert bio-
logical functions through mediating interactions with various
proteins, such as laminin, thrombospondin, amphoterin, selec-
tins, galectin, and hepatocyte growth factor (Roberts et al.
1985; Aruffo et al. 1991; Suzuki et al. 1993; Kobayashi et al.
1994; Shikata et al. 1999; Rouhiainen et al. 2000; Merten
and Thiagarajan 2001; Ideo et al. 2005). Some of these pro-
teins are adhesion molecules that are involved in cell–cell
and cell–extracellular matrix interactions. In this context,
selectins and laminin were shown to be involved in metastasis
(Roberts et al. 1985; Aruffo et al. 1991; Kobayashi et al.
1994; Shikata et al. 1999).
Selectins are vascular adhesion molecules involved in leu-
kocyte trafﬁcking, inﬂammation, thrombosis, autoimmunity,
and cancer (Varki 1994; Kansas 1996). The selectin family
(P-, E-, and L-selectin) recognizes sialyl Lewisx/a-containing
structures, which are normally found on mucin-type glyco-
proteins of leukocytes and endothelium (Dennis and Laferte
1987; Nakamori et al. 1993; Hakomori 1996; Kannagi 1997).
The observed correlation between sialyl Lewisx/a expression
and a poor prognosis due to tumor progression and metastasis
(Nakamori et al. 1993; Hakomori 1996) was further validated
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in different mouse models, where E-, P-, and recently also
L-selectin were associated with metastatic progression
(Biancone et al. 1996; Kim et al. 1998; Borsig et al. 2001,
2002; Ludwig et al. 2004). In addition to sialylated and fuco-
sylated mucin structures, P- and L-selectin are able to efﬁ-
ciently bind sulfatides (Aruffo et al. 1991; Suzuki et al. 1993;
Bajorath et al. 1994; Ishizuka 1997). L-selectin mediation of
monocyte inﬁltration in renal interstitial inﬂammation was
shown to be facilitated by sulfatides, thus demonstrating
sulfatides to be endogenous ligands of L-selectin (Shikata
et al. 1999). Human neutrophils could be activated by
sulfatides through L-selectin binding (Laudanna et al. 1994).
Additionally, P-selectin was shown to bind efﬁciently
sulfatides on the plasma membranes of granulocytes and
human tumor cells in vitro (Aruffo et al. 1991).
Elevated levels of sulfatides were detected in gastric,
hepatocellular, and renal cell carcinomas (Hiraiwa et al. 1990;
Kobayashi et al. 1994; Morichika et al. 1996), which was
shown to be due to upregulation of CST (Morichika et al.
1996; Ishizuka 1997; Honke et al. 1998; Zhong Wu et al.
2004). Signiﬁcantly higher expression of sulfatides in colorec-
tal carcinomas and ovarian carcinomas was correlated with
poor prognosis (Morichika et al. 1996; Makhlouf et al. 2004).
Sulfatides were shown to mediate carcinoma adhesion to
laminin and vitronectin, thereby modulating metastatic poten-
tial of renal cell and hepatocellular carcinomas (Kobayashi
et al. 1994; Zhong Wu et al. 2004). Alteration of glycolipid
expression, including expression of sulfatides, led to speciﬁc
reduction of laminin-mediated attachment and migration
(Inokuchi et al. 1990). Although sulfatide-mediated inter-
actions of carcinomas with selectins were shown in vitro, their
potential to facilitate metastasis had not been investigated.
Carcinoma-associated P-selectin ligands are mostly
sialylated, fucosylated glycans on tumor cell mucins (Byrd
and Bresalier 2004). Previously, we suggested the possibility
that sulfoglycosylceramides could be involved in selectin-
mediated metastasis (Borsig et al. 2002). Here we validate
sulfatides as functional P-selectin ligands and evaluate their
potential to facilitate metastasis of mouse carcinoma cells.
Results
Mouse colon carcinoma cell line MC-38 contains sulfated
selectin ligands
Previously, we showed that MC-38 cells possess ligands for
L- and P-selectin (Borsig et al. 2002). However, the nature of
the ligands had not been fully determined. To identify the
functional selectin ligands, MC-38 cells were stained with
recombinant selectin chimeras after treatment with different
carbohydrate-degrading enzymes and analyzed by ﬂow cyto-
metry. Initial analysis has shown that P-selectin ligands on
MC-38 cells are not mucins (Borsig et al. 2002). Therefore,
we checked for other potential selectin ligands, glycosamino-
glycans, and sulfatides (Varki 1997). Treatment of carcinoma
cells with a mixture of glycosaminoglycan-hydrolyzing
enzymes (heparinase and chondroitinase) did not affect
binding of P-selectin, but partially decreased recognition by
L-selectin (Figure 1A). The removal of sulfate groups by
arylsulfatase treatment resulted in a clear reduction of
P-selectin binding, as well as a reduction of L-selectin
binding, although to a lesser extent (Figure 1A). Although
L-selectin binding to MC-38 cells was calcium-dependent,
the binding of P-selectin was only partially affected by the
absence of calcium (Figure 1A) (Borsig et al. 2002). These
data suggested that L-selectin ligands on MC-38 cells are
represented partially by glycosaminoglycans, which was in
agreement with the EDTA sensitivity (Koenig et al. 1998).
Earlier we have shown that L-selectin binds mucin-type
ligands also (Borsig et al. 2002). Meanwhile, P-selectin
recognized a unique type of ligands in a calcium-independent
manner. Together with the requirement for sulfation, but
independent of glycosaminoglycans, the nature of the
P-selectin ligand appeared to be sulfoglycolipids (Needham
and Schnaar 1993; Koenig et al. 1998).
To conﬁrm that MC-38 cells interact also with P-selectin-
expressing cells, we tested the adherence of these cells to
Fig. 1. Characterization of the nature of selectin ligands on MC-38 cell
surfaces. (A) MC-38 cells were stained with mouse selectins and analyzed by
ﬂow cytometry. P-selectin [(a) and (c)] and L-selectin [(b) and (d)] stained
untreated cells are represented by bold solid lines. Filled areas [(a) and (b)]
represent controls stained with the secondary antibody Ab only. The dashed
line represents selectin-stained cells after heparinase–chondroitinase
treatment, whereas the thin line represents selectin-stained cells after
arylsulfatase treatment. Thin line [(c) and (d)] represents selectin staining in
the presence of 30 mM EDTA. (B) Adhesion of MC-38 cells to immobilized
platelets. Arylsulfatase-treated or sham-treated MC-38 cells were incubated
on slides with activated platelets for 20 min under low shear. Adherent cells
were counted.
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activated platelets. Slides with immobilized activated platelets
were incubated with MC-38 cells while shaking on an orbital
shaker (Figure 1B). Tumor cells adhered readily to activated
platelets, and this adherence was blocked by function-
blocking anti-P-selectin antibody. Arylsulfatase treatment
also led to reduction of adherence, although to a lesser
extent. The incomplete inhibition of tumor cell–platelet inter-
actions by removal of sulfation corresponded to incomplete
reduction of P-selectin binding to MC-38 cell (Figure 1A).
Finally, there was no adherence of MC-38 cells to nonacti-
vated platelets (data not shown). Thus cell-surface ligands of
MC-38 cells enable the adherence to platelets in a P-selectin-
dependent manner.
P-selectin binds to ligands in lipid fractions of MC-38 cells
To check whether P-selectin recognizes sulfated glycolipids
as functional ligands on MC-38 cell surfaces, total lipid
extract from these cells was prepared. Isolated lipids were
separated by Folch partitioning into a lower phase
(LP lipids), consisting of neutral glycolipids smaller than
tetrasaccharides, together with phospholipids and sulfated
glycolipids (sulfatides), and an upper phase (UP lipids) con-
taining mostly gangliosides. Lipid fractions were coated on
ELISA plates and analyzed by P-selectin chimera binding
(Figure 2A). Sulfated galactosylceramide [HSO3-3Galb-1Cer
(SM4)], a recognized P-selectin ligand, was used as a control
(Aruffo et al. 1991). Although P-selectin bound to LP lipids,
there was no recognition of UP lipids (data not shown). The
extent of P-selectin binding to LP lipids was comparable with
the recognition of SM4. The LP lipids from Folch partition
contain sulfatides and phospholipids, which are known poten-
tial P-selectin ligands (Malhotra et al. 1996). To conﬁrm that
sulfation is a prerequisite for P-selectin recognition, LP lipids
were treated with arylsulfatase prior to P-selectin chimera
binding. Desulfation of the LP lipids reduced binding of
P-selectin by more than 55% compared with about a 45%
reduction of binding to SM4 (Figure 2A). P-selectin binding
to LP lipids was only partially affected by the presence of
EDTA, which was similar to P-selectin recognition of SM4.
Recognition of the LP lipids was not affected by neuramini-
dase treatment, conﬁrming that the P-selectin binding is
independent of sialic acid (Borsig et al. 2002).
To identify P-selectin ligands in LP and UP lipid fractions,
lipid samples were separated by high-performance thin layer
chromatography (HPTLC) (Figure 2B and C). The large
amount of phospholipids in the LP lipid fraction was hydro-
lyzed by treatment with phospholipase C (PLC) prior to
separation on TLC plates. Visualization of glycolipids by
orcinol–sulfuric staining revealed the presence of a broad
panel of glycolipids. The majority of glycolipids in the LP
phase (lane 2) were migrating slower than the sulfatide SM4
(lane 1). Developing conditions for HPTLC were chosen so
that the best resolution of short oligosaccharide-chain glyco-
lipids and sulfatides would be achieved. Thus, an accumu-
lation of gangliosides with minimal migration was visible in
the UP lipid fraction (lane 3). Despite the large variety of
lipids in each fraction, P-selectin bound only to two distinct
lipid bands in the LP fraction of MC-38 cells (Figure 2C).
There was no binding to lipids in the UP fraction, suggesting
no recognition of sialic acid-containing gangliosides (Borsig
et al. 2002). As a positive control, SM4 was used, and a
neutral glycolipid marker served as a negative control (lanes
1 and 4). The lipids recognized by P-selectin corresponded to
a band with high mobility that migrated close to the SM4 sul-
fatide (Band I), whereas the more diffuse Band II migrated
with slower mobility. When the P-selectin overlay of a TLC
plate was prepared in the presence of EDTA, no visible
reduction of binding was observed (data not shown). To test
whether the Band I corresponds to sulfated-lactosylceramide
[HSO3-3Galb-4Glcb-1Cer (SM3)], we analyzed cell extracts
of HepG2 cells, which are known to contain SM3 sulfatide
(Spitalnik et al. 1989). P-selectin was found to bind the SM3
sulfatide, but this lipid band did not correspond to Band I of
MC-38 cells (see Supplementary Material).
Sulfation determines P-selectin ligands on MC-38 cells
To conﬁrm the presence of sulfate groups in the MC-38 lipid
bands recognized by P-selectin, cells were metabolically
labeled with sodium 35sulfate, and glycolipids were isolated.
Labeled lipid extracts were separated by HPTLC, and the
location of the radioactive signal on the plate was determined
by ﬁlm exposure. Sulfate incorporation was detected in the
region of Band I as a double band (Figure 3A). The appear-
ance of a double band by metabolic labeling is typical for
glycolipids, which indicates a difference in hydroxylation of
Fig. 2. Lipid extracts of MC-38 cells contain P-selectin ligands. (A) ELISA
plates were coated with LP lipids isolated by Folch partitioning (white bars)
and with bovine sulfatide-SM4 (black bars) as a control. “No treatment”
represents P-selectin binding to extracted lipids. “EDTA” represents
P-selectin binding to lipid fraction in the presence of 30 mM EDTA. The
third and fourth sets show P-selectin recognition of lipids after enzymatic
treatment, desulfation, or desialylation, respectively. Data shown are
mean+ SD of triplicates. The difference between nontreated lipids and
arylsulfatase-treated lipids (both MC-38 extracts and SM4 sulfatide) were
statistically signiﬁcant; as determined by one-way ANOVA followed by a
pairwise t test, P, 0.001. [(B) and (C)] MC-38 lipid extracts were separated
by HPTLC and developed in chloroform:methanol:0.2%CaCl2 (60:35:7).
Loading of samples: SM4 (lane 1); LP lipids from MC-38 cells (lane 2); UP
lipids of MC-38 cells (lane 3), and a neutral ganglioside marker (lane 4). (B)
Glycolipids visualized by orcinol–sulfuric acid staining. (C) P-selectin
overlay of separated lipid ligands.
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their acyl chains. However, there was no signal detected in
the region of Band II, indicating that these lipids are not
sulfate-containing structures. Indeed, MS/MS analysis of
these fractions only detected a series of glycerophosphoinosi-
tides in this fraction, in contrast to the same P-selectin-
binding band from HepG2 cells, where SM2a and SM3 with
a short ceramide chain were found, next to the same glycero-
phosphoinositides (see Supplementary Material). The
visualization of glycolipids by orcinol revealed a typical
glycolipid pattern as seen before (Figure 2B), whereas
P-selectin staining conﬁrmed the 35S sulfate-labeled band to
contain selectin ligands (data not shown).
The requirement of sulfation for P-selectin ligand
recognition was further conﬁrmed by an inhibition of sulfate
metabolism. MC-38 cells were incubated in the presence of
sodium chlorate, a known inhibitor of PAPS (30-phosphoade-
nosine 50-phosphosulfate) formation, which is the sulfate
donor (Ishizuka 1997). P-selectin binding to sodium
chlorate-treated cells was clearly reduced, as detected by ﬂow
cytometry (Figure 3B). The extent of P-selectin binding
reduction was comparable with arylsulfatase treatment. To
conﬁrm that the reduced P-selectin binding to MC-38 after
arylsulfatase treatment eliminates the same selectin ligands as
achieved by sodium chlorate treatment, MC-38 cells were
treated with arylsulfatase, followed by sodium chlorate
incubation (Figure 3C). The sequential treatment of MC-38
cell did not show any further decrease of P-selectin binding,
thereby indicating that both treatments targeted the same
ligands. Similarly, the binding of P-selectin to HepG2
cells was reduced by sodium chlorate treatment (see
Supplementary Material). All data taken together, we
concluded that the Band I P-selectin ligand on MC-38 cells is
a sulfated glycolipid.
MALDI-TOF/TOF analysis identiﬁed SM4 as P-selectin
ligand on MC-38 cells
To characterize the glycolipid recognized by P-selectin on
MC-38 cells (Band I in Figure 3A), the LP lipids were
treated with PLC and/or were saponiﬁed prior to puriﬁcation
on a DEAE-sepharose column. The charged glycolipid
fraction was collected and separated by HPTLC. P-selectin
immuno-overlay of the plate conﬁrmed the presence of a
P-selectin ligand (Figure 4A). The puriﬁed samples were ana-
lyzed by mass spectrometry (MS) as described in the
Materials and methods section (Figure 4B–D). In nonsaponi-
ﬁed samples, we detected two families of compounds: one
family represented the sulfatide SM4, with the heterogeneity
contributed by the lipid part (chain length differences,
presence of hydroxylation, and saturation levels of the fatty
acid). The slight difference in mobility of Band I, in compari-
son with SM4 standard as observed by HPTLC (Figure 2C),
is possibly due to the total lipid load in the LP lipid–TLC
lane. Moreover, a higher fraction of the SM4-ceramide in
MC38 cells is hydroxylated compared with the standard
SM4, which typically reduces the mobility under the TLC
conditions used here. The other family of compounds was
identiﬁed as cardiolipin (CL) by MS/MS analysis (data not
shown). CL has been reported to be virtually exclusively con-
ﬁned to mitochondria, with the exception of apoptotic cells,
where it can be found at the plasma membrane (Sorice et al.
2004). Therefore, it is probably an unlikely candidate for the
P-selectin ligand on the surface of cancer cells. Nevertheless,
we conﬁrmed in vitro by repeating the overlay experiment
with puriﬁed CL from a commercial source that CL is indeed
a P-selectin ligand (our unpublished results). At this point,
we cannot exclude that CL is also a biological ligand for
P-selectin. Upon saponiﬁcation of the sample, the CL peaks
disappeared from the spectrum as expected, whereas the SM4
peaks remained with unaltered distribution. The P-selectin
binding signal in the saponiﬁed fraction (Figure 4A, lane 3)
was rather weak, yet clearly present. These ﬁndings indicate
that SM4 is a P-selectin ligand in MC-38 cells.
MC-38 cell surface P-selectin ligands are SM4 sulfatides
The identiﬁcation of SM4 sulfatide in MC-38 cell lipid
extracts, together with P-selectin binding to intact cells
treated with hydrolytic enzymes (Figure 1), strongly
suggested that SM4 sulfatide is the primary P-selectin ligand.
To provide further evidence that SM4 sulfatide is indeed the
cell surface ligand of P-selectin, we analyzed MC-38
cells with altered glycolipid biosynthesis. We have shown
that an inhibition of sulfate metabolism led to a decrease of
P-selectin binding (Figure 3B). When exogenous SM4 sulfa-
tide was added to untreated cells, no alteration of P-selectin
binding was observed (Figure 5A). However, the addition of
Fig. 3. P-selectin ligand recognition requires sulfation. (A) MC-38 cells were
metabolically labeled with 35S sodium sulfate as described in the Materials
and methods section. Lipid extracts were separated by HPTLC, and the
incorporation of the radio-labeled sulfate was detected by exposure to X-ray
ﬁlm with a subsequent visualization by orcinol–sulfuric acid staining. (B)
MC-38 cells were incubated in the presence of 100 mM sodium chlorate for
72 h before staining with P-selectin and ﬂow cytometry analysis. Bold line
represents cells treated with sodium chlorate; shaded area represents
cells not treated; thin line represents cells treated with arylsulfatase only.
(C) P-selectin staining of MC-38 cells. (a) MC-38 cells were treated with
arylsulfatase (bold line) and compared with sham-treated cells.
(b) Arylsulfatase-treated cells were further incubated for 72 h in the presence
of sodium chlorate (thin line). Bold line represents sham-treated cells (a),
which were incubated in sodium chlorate. Shaded area represents
sham-treated cells incubated in normal medium as a control.
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exogenous SM4 sulfatide to sodium chlorate-treated cells
almost completely recovered P-selectin binding (Figure 5A).
This observation indicated that SM4 sulfatide can reconstitute
selectin ligands on MC-38 cells to the same level and
binding speciﬁcity. To conﬁrm the glycolipid nature of
P-selectin ligands, MC-38 cells were incubated in the pre-
sence of PPMP, an inhibitor of glucosylceramide synthase.
This treatment blocked synthesis of gangliosides and complex
sulfatides, only allowing the biosynthesis of galactose-linked
glycolipids, where the SM4 sulfatide is the predominant
product (Ishizuka 1997). The overall reduction of ganglio-
sides could be detected by orcinol staining of total lipid
extracts from equal number of cells, either PPMP-treated or
control cells (Figure 5B). The glucosylceramide biosynthesis
inhibitor treatment resulted in an enhanced binding of
P-selectin to cells (Figure 5A). This increase in P-selectin
binding was also observed in the absence of calcium, which
was in agreement with the partial calcium independence of
P-selectin recognition of a pure SM4 sulfatide (Figure 2A).
Finally, trypsin treatment of MC-38 cells did not affect
P-selectin binding, whereas a reduction in PSGL-1 epitopes
in a parallel treatment of HL-60 cells was observed (data not
shown). Taken together, these results provide evidence that
SM4 is the bona ﬁde P-selectin sulfoglycolipid ligand on
MC-38 cells.
Removal of cell surface sulfation attenuates metastasis
To ascertain whether SM4 sulfatide is the native P-selectin
ligand facilitating metastasis, we injected C57Bl/6J mice
with MC-38GFP carcinoma cells previously treated with
arylsulfatase. Lung sections from mice euthanized 30 min
after tumor cell injection were evaluated for platelet-MC-38
interactions (Figure 6A and B). Arylsulfatase treatment
reduced the platelet-thrombi formation around tumor cells.
Furthermore, platelet-tumor cell emboli formation of MC-38
cells is comparable with previously observed interactions of
platelets with human colon carcinoma cells, which carry
carcinoma mucins only (Kim et al. 1998; Borsig et al. 2001).
Fig. 4. MALDI TOF and TOF/TOF mass spectrometry analysis of the MC-38 P-selectin ligand. The speciﬁc band recognized by P-selectin was extracted from
the TLC plate and prepared for mass spectrometry analysis. (A) Immuno-overlay of the TLC-separated lipids with P-selectin. MC-38 lipid extracts from Folch
partitionings’ LP treated with PLC (lane 2) or saponiﬁed (lane 3) and puriﬁed on a DEAE column; SM4 sulfatide standard (lane 1). (B) Negative reﬂectron-
mode proﬁle of Band I recognized by P-selectin in MC-38 lipid extract treated with PLC. There are two families of peaks: a ﬁrst group around 890 m/z,
corresponding to SM4, and a second group around 1400–1475 m/z, corresponding to CL. Insert corresponds to SM4 region. (C1) Negative reﬂectron-mode
proﬁle of Band I recognized by P-selectin in MC-38 lipid extracts saponiﬁed with ammonia as described in the Materials and methods section. Insert
corresponds to SM4 region. CL is undetectable upon this saponiﬁcation procedure. (C2) MS/MS negative ion mode proﬁle of m/z 890.6. The fragment at
80 m/z represents the sulfate-speciﬁc radical anion [.SO3]
2, whereas the fragment at 97.1 m/z represents [HSO4]
2. Together, this ion fragment pair is diagnostic
for sulfated compounds under these conditions. The peaks at 241.1 and 259.1 m/z correspond to the B1- and C1- fragments, respectively, resulting from
cleavage of the glycosidic bond which links the hexose-sulfate moiety to the ceramide. Insert corresponds to the region 65–300 m/z. (D1) Negative reﬂectron-
mode proﬁle of SM4 standard after being puriﬁed by TLC as described in the Materials and methods section. Insert corresponds to SM4 region. A different
pattern of lipid heterogeneity of the SM4 spectra from MC-38 cells versus the standard could be observed. (D2) MS/MS negative ion mode proﬁle of m/z 888.5
in the standard. Insert corresponds to the region 65–300 m/z. Note the virtual identicalness of the fragment ion pattern between the standard SM4 and the
compound in (C2), further conﬁrming the identity of this compound as SM4.
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Thus, sulfatides on tumor cell surfaces are functional ligands
for platelets in vivo. When mice were euthanized 4 weeks
later, the extent of metastasis was evaluated (Figure 6C and
D). The lungs of mice injected with sham-treated carcinoma
cells were almost completely displaced by tumors, as
observed previously (Borsig et al. 2002). In contrast, mice
injected with arylsulfatase-treated carcinoma cells showed
virtually tumor-free lungs. Of the 10 mice, 8 had no or only
one visible metastatic foci (Figure 6C). The dramatic
reduction of metastasis was further conﬁrmed by ﬂuorescence
measurement of the lung homogenate (Figure 6D). To
exclude any possibility that the arylsulfatase treatment
impaired behavior of cells (Kobayashi et al. 1994; Uemura
et al. 2003), these were analyzed thoroughly in vitro. There
was no difference in viability, proliferation, adhesion, or
morphology of the treated cells when compared with sham-
treated cells (data not shown). Heparinase–chondroitinase-
treated cells behaved as the control cells and exhibited no
difference in proliferation, adherence, or morphology (data
not shown). Thus it is unlikely that the arylsulfatase treatment
affects glycosaminoglycans primarily. Arylsulfatase, but not
heparinase–chondroitinase, treatment of MC-38 cells also
reduced P-selectin-mediated platelet aggregation as observed
on lung sections at different time points after intravenous
injection. Furthermore, the number of tumor cells trapped in
the lung vasculature was lower in mice injected with arylsul-
fatase treated cells. This agrees with the previously shown
decrease in tumor cells seeding to the lungs when selectin
ligands on tumor cells were eliminated (Borsig et al. 2001).
The elimination of sulfation on MC-38GFP cells was associ-
ated with a reduced platelet aggregation and attenuation of
metastasis, conﬁrming the facilitating role of P-selectin in
this process.
Discussion
Sulfatides have been detected in various tissues, including the
brain, kidney, and gastrointestinal tract (Ishizuka 1997).
A systematic analysis of glycosphingolipids in human gastro-
intestinal tract has shown the presence of sulfatides, SM4 in
particular, in normal mucosa (Natomi et al. 1993). The pre-
ferential enrichment of sulfatides in the gastric mucosa
Fig. 5. Modulation of glycolipid biosynthesis affects P-selectin binding. (A) MC-38 cells were stained with mouse P-selectin and analyzed by ﬂow cytometry.
(a) MC-38 cells exposed to exogenous SM4 sulfatide did not alter P-selectin binding to cells (bold line). Filled area represents control cells without sulfatide
addition. (b) To sodium chlorate-treated MC-38 cells (bold line) was exogenously added SM4 sulfatide and the cells were stained with P-selectin (thin line).
Filled area represents binding of P-selectin to untreated cells. (c) MC-38 cells were incubated in the presence of PPMP for 72 h and stained with P-selectin
(bold line). P-selectin binding was only partially affected when incubated with 30 mM EDTA (thin line). Control cells, without glucosylceramide synthase
inhibitor, were stained with P-selectin without EDTA (ﬁlled areas) or in the presence of EDTA (dotted line). (B) Total lipid extracts from cells treated with
PPMP (PPMP) or untreated (control) were separated by HPTLC and stained by orcinol. Equal amount of cells has been extracted and loaded on TLC plate.
Reduction in monosialogangliosides as well as highly charged glycolipid could be observed.
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strongly indicates its possible involvement in mucosal protec-
tion. Sulfatides are also increasingly expressed in several
human cancer tissues, including the lung (Miyake et al.
1992), colon (Siddiqui et al. 1978; Osawa et al. 1997),
kidney (Sakakibara et al. 1989), liver (Hiraiwa et al. 1990),
and ovary (Kiguchi et al. 1992). Even though the pathological
correlation of sulfatides with cancer in these tissues remains
unclear, their enhanced expression was correlated with poor
metastatic prognosis (Morichika et al. 1996; Makhlouf et al.
2004). Here we provide one possible mechanism for how sul-
fatides might contribute to metastasis in a syngeneic mouse
model. First, SM4 sulfatide was shown to be virtually the
sole P-selectin ligand on colon carcinoma cells (MC-38), as
determined by MALDI-TOF/TOF analysis of puriﬁed glyco-
lipids. Secondly, P-selectin-mediated interactions with MC-
38 cells through SM4 sulfatide were shown to facilitate
metastasis, thus identifying SM4 sulfatide to be a functional
native ligand in this process. Previously, we and others have
shown that the absence of P-selectin led to attenuation of
metastasis (Kim et al. 1998; Borsig et al. 2001; Ludwig et al.
2004). Here we show that enzymatic removal of sulfation
from tumor cells prior to intravenous injection strongly
attenuates metastasis. This observation is in agreement with
previous ﬁndings that any interference in P-selectin-mediated
interactions between tumor cells and platelets and/or endo-
thelium, achieved either by removal of ligands from tumor
cells or by temporal inhibition by heparin, resulted in attenua-
tion of metastasis, indicating their function in early steps of
metastasis (Borsig et al. 2001, 2002; Fuster et al. 2003;
Ludwig et al. 2004). Therefore, sulfatides on tumor cells
could serve as ligands for P-selectin-mediated interactions,
thereby contributing to metastatic spread.
Sulfatides and glycosaminoglycans (e.g. heparin and
chondroitin sulfate) represent other nonsialylated ligands for
selectins, which are expressed on several carcinomas and also
on human granulocytes (Aruffo et al. 1991; Nelson et al.
1993; Suzuki et al. 1993; Kawashima et al. 2000). L-selectin
was shown to bind not only SM4 sulfatide, but also
Fig. 6. Elimination of cell surface sulfation attenuates metastasis. Mice were injected intravenously with 3–4  105 MC-38GFP cells either treated with
arylsulfatase or sham treated. (A) Platelet interactions with injected cells were evaluated in lungs from mice terminated 30 min after injection. Representative
images untreated-control tumor cells (green) with associated platelets (red), which were largely diminished when MC-38 cells were treated by arylsulfatase prior
to injection. Blue are stained nuclei. (B) Quantiﬁcation of platelet–tumor cell interactions from three independent experiments. [(C) and (D)] Mice were
euthanized after 28 days, lungs were dissected and photographed, and GFP ﬂuorescence in the lung homogenate was quantiﬁed. The number of animals studied
was 8–9 in each group. (C) Representative examples of dissected lungs from mice injected with arysulfatase treated (þ) and sham treated (2) MC-38GFP cells.
(D) The extent of metastasis was measured by GFP ﬂuorescence analysis of lung homogenate. Statistical signiﬁcance was determined by the Student t test.
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sulfated lactosylceramide SM3 and sulfated tri- and
tetra-glycoceramides GalNAcb-4(HSO3-3)Galb-4Glcb-1Cer
(SM2) and SB1a, respectively (Suzuki et al. 1993).
Conversely, P-selectin was demonstrated to bind SM4 sulfa-
tide only (Aruffo et al. 1991). Here we show that P-selectin
is also able to recognize SM3, and SM2 sulfatides, which
were found in HepG2 cells (Supplementary Material). This
observation indicates that a variety of sulfatides can be recog-
nized by P-selectin. Whether sulfatides expressed on variety
of human carcinomas contribute to metastatic spread through
selectin-mediated interaction requires further studies.
Interestingly, sulfatides were found to facilitate P-selectin-
mediated platelet adhesion and aggregation (Merten and
Thiagarajan 2001). The recent ﬁnding that sulfatides could
lead to platelet activation and their aggregation with leuko-
cytes suggest this mechanism to play an important role in
hemostasis and thrombosis (Merten et al. 2005). In this
context, our ﬁnding that murine colon carcinoma cells carry-
ing sulfatides can effectively induce P-selectin-mediated
platelet aggregation raises the possibility for the involvement
of these interactions also during hematogenous metastasis.
The negatively charged phospholipid CL is normally
conﬁned to the mitochondrial inner membrane (Schlame
et al. 2000). In addition, CL was also detected on the cell
surface of apoptotic cells after redistribution from mitochon-
dria (Sorice et al. 2004). Modulation of the internal CL pool
by palmitate was associated with apoptosis of breast cancer
cells (Hardy et al. 2003). We have shown that CL can be pur-
iﬁed from membranes of MC-38 cells and is recognized by
P-selectin. By HPTLC separation, CL was co-migrating with
SM4 sulfatide and could be eliminated by saponiﬁcation
only. Interestingly, signiﬁcant amounts of CL were found in
MC-38 cell extracts, although CL usually comprises a minor
component of the total lipid extracts in other cell lines (our
unpublished results). Previously, L-selectin was shown to
bind CL in calcium-independent manner (Malhotra et al.
1996). We have conﬁrmed that P-selectin can bind CL.
Whether the enhanced presence of CL in MC-38 has any
biological relevance for P-selectin recognition remains to be
elucidated. Nevertheless, MC-38 cells after sulfatase treat-
ment or inhibition of sulfate metabolism by sodium chlorate
showed signiﬁcantly reduced P-selectin binding, strongly
suggesting that the main ligand for P-selectin-mediated
metastasis is a sulfoglycolipid.
The association of enhanced sulfatide expression on cancer
cells with metastasis has not been fully clariﬁed. Human
renal-cell carcinoma and hepatocellular carcinoma cells
require cell surface expression of sulfoglycolipids for attach-
ment to laminin (Kobayashi et al. 1994; Zhong Wu et al.
2004). Incorporation of externally supplemented SM4 sulfa-
tide increased haptotactic migration of cancer cells on
laminin, which was associated with accelerated lung coloniza-
tion (Kobayashi et al. 1994). The presence of sulfatides on
cancer cells was correlated with the expression of ceramide
sulfotransferase gene (CST) (Honke et al. 1998) and associ-
ated with metastatic potential of human hepatocellular carci-
noma cells (Zhong Wu et al. 2004). Expression of particular
sulfatides was also found to be dependent on the availability
of precursor glycolipids (Kobayashi et al. 1994; Zhong Wu
et al. 2004). Meanwhile, the presence of SM3 sulfatide was
linked to upregulation of CST gene expression, which also
mediated cell adhesion to vitronectin and aVb3 integrins
(Honke et al. 1998; Zhong Wu et al. 2004). On the contrary,
expression of SM3 sulfatide induced by CST transfection in
murine Lewis lung carcinoma cells led to suppression of
cell adhesion to laminin and b1 integrin and, subsequently,
metastasis (Kabayama et al. 2001; Uemura et al. 2003). The
discrepancy between these results may be due to the
clonal nature of the Lewis lung carcinoma cells and the sub-
sequent differences in their signal transduction (Kabayama
et al. 2001; Uemura et al. 2003). Recently, sulfatides were
also found to be potential native ligands for Galectin-4, a
galactose-binding lectin (Ideo et al. 2005). Our ﬁndings
propose that SM4 sulfatide is contributing to metastasis
through P-selectin-mediated interactions with platelets and/or
endothelium. The extent of metastasis observed with
MC-38GFP cells devoid of sulfation, and thereby P-selectin
ligands (Figure 6), was even less than that observed in
P-selectin-deﬁcient mice (Borsig et al. 2002). Thus it is likely
that sulfatides may contribute to metastasis by more than one
mechanism. Further studies are needed to elucidate how
P- and/or L-selectin binding to sulfatides affects metastasis.
Materials and methods
Cell lines and reagents
Mouse colon carcinoma cell line MC-38 (Borsig et al. 2002)
was grown in DMEM with high-glucose (10% fetal calf
serum [FCS]) medium (Invitrogen, Carlsbad, CA). For exper-
imental metastasis studies, we used cells stably expressing
GFP (MC-38GFP) (Borsig et al. 2002). All reagents were
from Sigma (St. Louis, MO) unless otherwise stated.
Flow cytometry analysis of MC-38 cells
Cells were grown to 90% conﬂuency, detached by incubating
in PBS, containing 2 mM EDTA, for 5 min at 37 8C, and
washed three times with the cold Hank balanced salt solution
(HBSS). After blocking with HBSS containing 1% BSA
(HBSS/BSA), cells were incubated with mouse P- or
L-selectin chimeras, containing the Fc region of human IgG
(Borsig et al. 2002). Prior to addition to tumor cells, selectin
chimeras were preincubated with a biotinylated goat-
antihuman IgG Ab (1:200) for 1 h at RT in HBSS/BSA.
After incubating tumor cells with preconjugated selectin
chimeras for 1 h at 4 8C, Streptavidin-PE-Cy5 (Becton
Dickinson, Mountain View, CA) was added and incubated for
20 min. Cells were washed with HBSS/BSA and analyzed by
ﬂow cytometry. As controls, cells were stained with P-selec-
tin chimera in the presence of 5 and 30 mM EDTA, respect-
ively (Borsig et al. 2002). In some cases, tumor cells were
enzymatically treated prior to incubation with selectin chi-
meras. Glycosaminoglycans were removed by treatment with
a mixture of heparinase II and chondroitinase ABC in HBSS
for 1 h at 37 8C (Borsig et al. 2002). Sulfate groups were
eliminated by arylsulfatase H-5 treatment in HBSS buffer for
1 h at 37 8C.
MC-38 cells adhesion to immobilized platelets
Mouse platelets were isolated and labeled with Calcein AM
(Invitrogen, Carlsbad, CA), as previously described (Kim
et al. 1998). Glass chamber slides (LabTek, Nunc, Rochester,
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NY) were pretreated with 4% solution of 3-aminopropyl-
triethoxysilane (Buttrum et al. 1993). Isolated platelets were
added to the chamber slides and spun at 200g for 10 min.
Slides were blocked by PBS/BSA for 10 min. Platelets were
activated with thrombin (1 U/mL) for 10 min. Even coating
of the slide by platelets was conﬁrmed by ﬂuorescence
microscopy. Slides coated with platelets were loaded with
20 000 MC-38 cells/well and incubated for 20 min on
Orbital shaker (Heidolph Instruments, Schwabach, Germany)
at 70 rpm (Koenig et al. 1998). In some cases, P-selectin
expressed of platelets was blocked by an addition of 6 mg of
function-blocking P-selectin antibody (BD Pharmingen).
After incubation, nonattached cells were aspirated, and slides
were washed once with PBS. Attached MC-38 cells were
counted at the microscope 12 view ﬁelds by 100
magniﬁcation.
Lipid extraction from MC-38 and HepG2 cells
Semiconﬂuent cells were detached with PBS containing
2 mM EDTA and washed three times with HBSS. Cells were
resuspended in water and homogenized by sonicating three
times for 1 min. Lipids were extracted with 10 volumes of
chloroform/methanol (1:1) for 4 h at RT while shaking.
Supernatants containing lipids were separated by centrifu-
gation, and the cell pellet was re-extracted with chloroform/
methanol (1:1) overnight. Pooled lipid-rich supernatants were
separated by Folch partition (Schnaar 1994), where two
phases were obtained: the UP containing less hydrophobic
lipids and the LP containing more hydrophobic lipids. The
UP was dialyzed against water. The LP was treated with PLC
in 50 mM potassium phosphate buffer, pH 7.4 (Sonnenburg
et al. 2002), and incubated at 37 8C for 3 h while vigorously
shaking, followed by dialysis against water and drying down.
The sugar content of the lipid extract was measured by a
phenol–sulfuric acid colorimetric assay (Dubois et al. 1956).
Brieﬂy, an aliquot of the lipid preparation or various concen-
trations of glucose were added to a glass vial and brought to
200 mL with water. Phenol was added (to 5% ﬁnal concen-
tration) together with 1 mL of concentrated sulfuric acid.
Probes were vigorously mixed and the absorbance was
measured at 490 nm. Sugar content of the lipid extract
was calculated against a standard curve obtained from the
various glucose solutions.
ELISA analysis of lipids from MC-38 cells
Lipids, along with bovine sulfatide (SM4) as a control, were
resuspended in methanol and used for coating of the ELISA
plates by evaporating the methanol (Borsig et al. 2002). The
wells were washed with HBSS and blocked with 0.5% BSA
in HBSS for 1 h at RT. Mouse selectin chimeras were prein-
cubated with goat-antihuman IgG Ab conjugated with alka-
line phosphatase (1:100) for 1 h at RT. Preincubated selectins
were added into the wells and incubated for 2 h at RT in the
absence or presence of 30 mM EDTA, followed by three
washes with HBSS. After a ﬁnal wash, the p-nitrophenyl
phosphate substrate was added and allowed to develop for
20 min at RT, after which absorbance was measured at
405 nm. Some lipid samples were enzymatically treated prior
to coating on ELISA plates (Hiraiwa et al. 1990). Brieﬂy, ali-
quots of lipid fractions were placed in glass vials and dried
down under a N2 stream. Samples for arylsulfatase H-5
treatment were resuspended in 50 mM acetate buffer, pH 5.0,
whereas those for neuraminidase treatment were treated in
50 mM citrate buffer, pH 5.0. After treating for 90 min at
37 8C, lipids were dried down and resuspended in methanol.
High-performance thin layer chromatography (HPTLC)
Fifteen microgram of glucose equivalents of our sample
were applied to a preactivated silica plate (MERCK,
Darmstadt, Germany). Plates were developed in a TLC tank
pre-equilibrated with chloroform/methanol/0.25% CaCl2
(50:40:10) or with chloroform/methanol/0.2%CaCl2
(60:35:7). SM4 and a neutral ganglioside mix (Matreya) were
used as markers. Glycolipids were visualized by the orcinol–
sulfuric acid reagent.
TLC immuno-overlay
Samples were applied to TLC plates and developed as
described in HPTLC. Dried plates were plastiﬁed in a sol-
ution of Hexane/2% polyisobutylmethacrylate (ALDRICH)
in chloroform (84:16) (Schnaar 1994). Air-dried plates were
incubated with a blocking solution, HBSS-containing 5%
BSA, for 2 h at RT, followed by incubation with P-selectin
chimera (Borsig et al. 2002) in HBSS/BSA overnight at
4 8C. Plates were washed three times with HBSS/BSA and
incubated with a secondary antibody conjugated with horse-
radish peroxidase for 1 h at RT. After three washes with
HBSS, plates were developed with 400 mg/mL o-phenylen-
diamine in 50 mM citrate–phosphate buffer, pH 5.0, with
0.12% hydrogen peroxide and dried (Sonnenburg et al.
2002).
Metabolic 35S labeling of lipids
MC-38 cells were grown in T175 ﬂasks until 80% conﬂuent.
The complete medium was changed for a low-sulfate medium
containing Met (7.5 mg/L) and Cys (50 mg/L) supplemented
with 10% dialyzed FCS. After sulfate-starving for 3 h, cells
were labeled with 0.5 mCi of sodium [H35SO4]
2 in the
low-sulfate medium for 16 h (Tooze 2003). Labeled cells
were washed with PBS and detached with PBS/2 mM EDTA.
Total lipids were extracted from the cells as follows: the cell
pellet was resuspended in ﬁve volumes of H2O and vortexed
and bath-sonicated followed by an addition of 10 volumes of
chloroform/methanol (1:1). Lipids were extracted for 3–4 h
at RT while shaking vigorously. Samples were centrifuged at
4 8C to pellet the precipitates. The supernatant was trans-
ferred into a new tube and stored at 4 8C. The pellet was re-
extracted overnight in a similar volume of chloroform/metha-
nol (1:1). Both lipid extractions were pooled and dried down.
Samples were resuspended in methanol, loaded on a TLC
plate, and developed as described in HPTLC. Lipids, which
incorporated sulfate, were revealed by exposure to X-ray ﬁlm
(Kodak) for 15 days. The TLC plate was stained with
orcinol–sulfuric reagent.
Puriﬁcation of sulfoglycolipids through anion exchange
chromatography (DEAE–sepharose) and preparative HPTLC
To hydrolyze triacylglycerides, glycerophospholipids, and
sphingolipids, the LP was saponiﬁed with ammonia solution
according to an adopted protocol (Ferguson 1993). The
samples were dried down and resuspended in a solution con-
taining a ﬁnal concentration of 17.5% ammonia in methanol.
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After incubation for 6 h at 50 8C, the preparation was dried
down in a SpeedVac centrifuge (Sovant Instruments,
Hicksville, NY) and washed twice with 50% methanol.
Separation of negatively charged lipids from neutral lipids
was performed as described previously (Schnaar 1994).
Brieﬂy, PLC-treated or saponiﬁed lower-phase lipid extract
was dissolved in solution A, chloroform/methanol/water
(30:60:8 v/v). The DEAE-sepharose (Amersham
Biosciences) was changed into acetate form by mixing the
dry resin with solution B, chloroform/methanol/0.8 M
aqueous sodium acetate (30:60:8 v/v). After washing the
column several times with solution A, the samples were
loaded and the ﬂow through was discarded. The negatively
charged lipids were eluted with several bed volumes of sol-
ution B. The eluate was dialyzed and samples were separated
by HPTLC. The areas corresponding to lipids recognized by
P-selectin were scratched and collected into a glass tube. To
recover the lipids from silica, samples were resuspended in
methanol, mixed, and spun down. The supernatant, contain-
ing the lipids, was transferred into a new tube and dried
down.
Modulation of cellular sulfatides
MC-38 cells and HepG2 cells were incubated in regular
medium containing 100 mM sodium chlorate for 72 h
(Xia et al. 2003). Cells were detached by 5 mM EDTA/PBS
treatment, and the extent of P-selectin binding was analyzed
by ﬂow cytometry. When the incorporation of externally
added SM4 sulfatide was evaluated, cells were resuspended
in HBSS containing 1% BSA at a concentration of
2  106 cells/mL and were incubated for 5 min with 10 mM
SM4 sulfatide at 37 8C (Kobayashi et al. 1994). Cells were
immediately put on ice, washed with ice-cold HBSS buffer,
and incubated with P-selectin. For the inhibition of glucosyl-
ceramide synthase, tumor cells were cultured in the presence
of 15 mM of D,1-threo-1-phenyl-2-hexadecanoylamino-3-mor-
pholino-propanol (PPMP; Matreya, Pleasant Gap, PA)
(Burdick et al. 2003; Dimitroff et al. 2004). After 72 h culti-
vation in the presence of the inhibitor, cells were stained with
P-selectin and analyzed by ﬂow cytometry.
Mass spectrometry
For MALDI-TOF and TOF/TOF mass spectrometry, prepara-
tive TLC was performed as described in HPTLC. Upon
solvent development, the aluminum-backed plate was cut
through the lane of interest. One-half was used for the detec-
tion of the regions of interest using P-selectin immuno-
overlay, upon which both halves of the plate were re-aligned,
and the silica present in narrow bands on the nonstained half
of the plate was scraped off and carefully collected. After
having experienced signiﬁcant losses of analytes on plastics
and chromatographic materials, we found that simple extrac-
tion of the silica with 100% methanol yielded preparations
that were sufﬁciently pure for direct analysis via MALDI-
TOF MS, although minimizing the chance for material loss
during sample workup. We used 192-spot polished stainless
steel targets for the ABI 4700 Proteomics Analyser. Small
droplets of the methanol extracts were applied onto the target
spot under a continuous stream of cold air to allow instan-
taneous drying. We repeated this sample application pro-
cedure until a whitish ﬁlm became visible on the dried target
spot (applying more sample results in decreased spectral
quality). We used a preparation of 20 mg/mL 6-aza-2-
thiothymine (ATT; Fluka, Buchs, CH) in 70% MeOH con-
taining 10 mM NH4-citrate for the matrix. One microliter of
this matrix preparation was spotted onto the sample-loaded
target spots and pipetted up and down to provide for proper
sample–matrix mixing. The drops were then left to dry. ATT
was chosen at the matrix by comparing this matrix for the
analysis of the SM4 standard with several other preparations
that have been reported in the literature to be useful for polar
lipids (2,5-dihydrozybenzoic acid, 2,5-dihydroxybenzoic
acid/5-methoxysalicylic acid co-matrix, 3-hydroxypicolinic
acid/6-hydroxypicolinic acid co-matrix, a-hydroxy-4-cyano-
cinnamic acid). The ATT matrix is exceptionally “clean” in
the low-m/z region, which is important for the analysis of
lipids, and is sufﬁciently “cold” to allow for intact ionization
of sulfated, mono- and di-sialylated, and phosphorylated
lipids. All the reported analyses were performed in the nega-
tive ion reﬂectron mode of the instrument, tuned for an
optimal sensitivity/resolution ratio for this matrix.
Calibration in the 900–4000-m/z range was performed using
a standard peptide mixture (ABI) in the same ATT matrix as
used for the lipid analytes. The spectra were obtained by the
summation of at least 50 subspectra, each averaged over 50
laser shots. TOF/TOF MS/MS analysis was carried out with
air at 5.10E–6 Torr as the collision gas, and the spectra were
obtained by the summation of 100 subspectra, each averaged
over 50 laser shots. The instrument was optimized to select
the parent ion +3–4 Da, which is the narrowest available
limit with this ion selector.
Methodological note: a mass spectrometry method to
distinguish sulfation from phosphorylation
Sulfation and phosphorylation of a certain class of biomole-
cules (in this case, polar lipids) can be very difﬁcult to
distinguish at trace levels. In the analytical situation we faced
here, sulfoglycolipids were present in a mixture with
phospholipids and, most problematically, with phosphoinosi-
tides. To obtain positive evidence for sulfation versus
phosphorylation, we made use of the fact that TOF/TOF
fragmentation follows the behavior of higher energy single
collision-induced fragmentation as is typical for triple
quadrupole and magnetic sector instruments, rather than the
behavior of low-energy multiple collision-induced fragmenta-
tion as is observed in most of the modern analyzers (ion
traps). In high-energy collision-induced dissociation (CID),
sulfated compounds yield the sulﬁte radical anion [.SO3]
2 at
m/z 80 and [HSO4]
2 at m/z 97. Phosphorylated compounds
yield [PO3]
2 at m/z 79 and [H2PO4]
2 at m/z 97 (Wilm et al.
1996). We report here that MALDI-TOF/TOF yields these
diagnostic high-energy CID ions very reliably and at
sufﬁciently high intensities to be potentially useful also in
phospho- versus sulfo-proteomics. We suspect that the extre-
mely short time between CID and detection in the TOF/TOF
geometry contributes to the radical anion being robustly
detected. Because Ser/Thr sulfation has recently been
described in a wide range of organisms and because the dis-
tinction between Ser/Thr sulfation and phosphorylation
cannot be made using the most common phosphoproteomics
methodology, the TOF/TOF analyzer will be extremely
useful for this purpose.
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Experimental metastasis assays
Mice (strain C57Bl/6J) were injected with 3–4  105
MC-38GFP syngeneic adenocarcinoma tumor cells, which
were either arylsulfatase or mock treated. After 4 weeks,
mice were euthanized, a picture of dissected lungs was taken,
and lungs were further processed for quantitation of metasta-
sis by detection of GFP ﬂuorescence (Borsig et al. 2002).
Supplementary material
Supplementary data are available at Glycobiology online
(http://glycob.oxfordjournals.org/).
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